CHESTGuidelines & Topic CollectionsThoracic Oncology

Thoracic Oncology

Advertisement

Must-reads and more in CHEST® journal portfolio

CHEST Journal image
JOURNAL CHEST®

Lung Cancer Screening Adherence in Centralized vs Decentralized Screening Programs

A Prospective, Multicenter Evaluation of Safety and Diagnostic Outcomes With Robotic-Assisted Bronchoscopy

CHEST® PULMONARY

Association of Communication With Smoking Attitudes and Behaviors Among Patients Undergoing Lung Cancer Screening: A Longitudinal Cohort Study

Racialized Economic Segregation and Disparities in Non-Small Cell Lung Cancer Care and Outcomes

GUIDELINES AND CONSENSUS STATEMENTS

Management of Patients With Early-Stage Non-Small Cell Lung Cancer

EARN CME CREDIT

Neighborhood-Level Socioeconomic Disadvantage and Adherence to Guidelines for the Evaluation of Patients With Incidentally Detected Pulmonary Nodules

CHEST JOURNAL PODCAST

Interventions to Improve Adherence to Clinical Guidelines for the Management and Follow-Up of Pulmonary Nodules: A Systematic Review
Justin Aunger, PhD; Kay Por Yip, MBChB, PhD; and Gretchen Winter, MD (moderator)

 
visual abstract
GRAPHICAL ABSTRACT

What Is the Impact of Pleural Effusion on Survival in Patients Hospitalized for Cancer, Congestive Heart Failure, or Pneumonia?

VIEW THE DOWNLOADABLE PDF

READ THE RELATED ARTICLE »

CHEST JOURNAL PORTFOLIO | Access even more thoracic oncology research. READ THE JOURNALS »

GUIDELINES BY TOPIC | Review practice-changing recommendations for thoracic oncology.
ACCESS THORACIC ONCOLOGY GUIDELINES »
ACCESS INTERVENTIONAL PULMONARY GUIDELINES »

On this page

RESOURCES

Clinician education resources

Patient education resources

NEWS

News and notes

Advertisement

 

Downloadable educational assets

Navigating Lung Cancer Screening program imagery

Navigating Lung Cancer Screening: Identifying and Engaging High-Risk Individuals

Despite the clear advantages of screening for early-stage, more treatable lung cancer, a surprisingly low percentage of eligible Americans undergo recommended screening. While current guidelines for lung cancer screening are largely consistent, the nuances in interpreting and applying these criteria to the patient in front of you can be perplexing, leading to lower screening rates. Utilizing clinical cases and related questions, Carla Lamb, MD, FACP, FCCP (Lahey Hospital & Medical Center), addresses these key points, offering guidance on how to identify high-risk patients suitable for screening. Additionally, it will provide strategies to facilitate shared decision-making with patients, focusing on a comprehensive discussion of the benefits and risks associated with screening. CME and ABIM MOC credit available.

This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

ACCESS PROGRAM »

Navigating Lung Cancer Screening program imagery

Join the Thoracic Oncology and Chest Procedures Network

CHEST Networks are specialty-focused communities that provide forums for leadership, education, and advocacy. The Thoracic Oncology and Chest Procedures Network advances the concept of multidisciplinary care and clinical practice for the patient and provider in the areas of interventional procedures, lung cancer, pleural disease, and ultrasound/chest imaging.

LEARN MORE »

Thoracic oncology news and notes

Follow the latest thoracic oncology news

PLEURAL DISEASE SECTION

Opening the Flood Gates: Pleural Complications of Immune Checkpoint Inhibitors
Pulmonologists and oncologists must start to consider pleural complications as a potential risk of immune checkpoint inhibitor therapy.

LUNG CANCER SECTION

EBUS Nodal Staging in Early-Stage Non-Small Cell Lung Cancer
EBUS-TBNA disrupted the field of bronchoscopy but recent data have emerged that show routine use of EBUS may warrant scrutiny.

ULTRASOUND AND CHEST IMAGING SECTION

Lung Ultrasound: An Indispensable yet Underutilized Tool
In the last year, LUS has shown utility beyond evaluation for pneumothorax, pulmonary edema, and pleural effusion.

INTERVENTIONAL PROCEDURES SECTION

In Our Navigational Bronchoscopy ERA
The VERITAS trial is a turning point for interventional pulmonology, ushering in an era of high-quality comparative effectiveness trials poised to transform our approach to technology evaluation, implementation, and, ultimately, patient care.

CHEST PHYSICIAN

New Data Confirms ILD as Lung Cancer Risk Factor
According to a large longitudinal study recently published in the Journal of the American Medical Association, ILD more than doubled the risk of lung cancer.

Noninferiority Data Move Navigational Bronchoscopy Into Frontline Lung Biopsy Discussion
Given the favorable safety profile seen in the VERITAS trial, investigator Matthew C. Aboudara, MD, FCCP, said the approach should be considered alongside CT scan-guided transthoracic needle biopsy.

Varenicline Found Effective for Nicotine Vaping Cessation in Youth
Results from a randomized trial suggest varenicline combined with behavioral counseling significantly improves vaping cessation rates among young people who do not regularly smoke tobacco.

ORCA-3 Replicates Strong Tobacco Cessation Results for Cytisinicline
If approved, the reformulation of cytisinicline would be the first new medication for smoking cessation in nearly 20 years.

Build your thoracic oncology expertise with CHEST education

CHEST SEEK® Education

Written and peer reviewed by renowned experts in the critical care, pulmonary, and sleep medicine fields, the online CHEST SEEK Library and print publications include case-based questions and detailed rationales to stimulate and challenge your clinical thought process; help you prepare for certification or recertification exams; and allow you to obtain CME credit, MOC points, and CE hours.

CHEST SEEK LIBRARY

Access hundreds of critical care, pulmonary, and sleep medicine questions.

PURCHASE NOW »

Join the community

If you’re not already a CHEST member, become one today for access to additional resources, discounts on educational activities, and networking opportunities.

JOIN NOW »